Maynard Um
-
-
-
-
-
-
-
GeneDX Holdings Investigated for Possible Securities Fraud; Investors Should Contact Block & Leviton to Recover Losses
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on GeneDx (WGS) on data moat, AI effeciency
-
-
-
-
-
-
-
GeneDx partners with Komodo Health to create rare disease dataset
-
-
-
-
-
-
-
GeneDx receives FDA breakthrough device designation for genome tests
-
-
-
-
-
-
-
Piper Sandler on GeneDx (WGS): 'Visibility to a Multiyear Growth Cycle'
-
-
-
-
-
-
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGS
-
-
-
-
-
-
-
GeneDx Holdings (WGS) spreader July 70 and 80 calls as share price down 5.7%
-
401,473 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

